The REALITY Study - Head-to-Head Comparison Between Cypher and Taxus
NCT00235092
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
1335
Enrollment
INDUSTRY
Sponsor class
Conditions
Coronary Artery Disease
Interventions
DEVICE:
Cypher Sirolimus-Eluting Stent
DEVICE:
Taxus Paclitaxel-Eluting Stent
Sponsor
Cordis US Corp.